Neutrophil-lymphocyte ratio is prognostic but not predictive of response to Abiraterone in metastatic castration-resistant prostate cancer
JRSM Open
.
2015 Nov 3;6(12):2054270415611332.
doi: 10.1177/2054270415611332.
eCollection 2015 Dec.
Authors
Santhanam Sundar
1
,
Michael O'Cathail
1
Affiliation
1
Nottingham University Hospitals NHS Trust, Nottingham, UK.
PMID:
26664732
PMCID:
PMC4668914
DOI:
10.1177/2054270415611332
No abstract available